W.R. Berkley (NYSE:WRB) Given New $62.00 Price Target at Barclays

Key Points

• Barclays cut its price target on W.R. Berkley to $62 from $64 and assigned an "underweight" rating, implying about a 7.2% downside from the prior close.
• Analyst views are mixed — several firms have trimmed targets recently, but the sell‑side consensus remains a Hold with a consensus target of about $69.06.
• Major insider accumulation: Sumitomo bought 370,000 shares (~$24.8M) and insiders own 23% of the stock while institutions own roughly 69%, signaling notable insider/institutional confidence despite cautious analyst notes.

W.R. Berkley (NYSE:WRB - Get Free Report) had its price objective lowered by research analysts at Barclays from $64.00 to $62.00 in a research note issued on Wednesday,Benzinga reports. The brokerage currently has an "underweight" rating on the insurance provider's stock. Barclays's price target indicates a potential downside of 7.20% from the stock's previous close.

A number of other equities analysts also recently commented on WRB. Mizuho dropped their price objective on W.R. Berkley from $69.00 to $67.00 and set a "neutral" rating on the stock in a report on Tuesday, January 27th. Argus dropped their price objective on W.R. Berkley from $82.00 to $76.00 and set a "buy" rating on the stock in a report on Monday, February 2nd. Morgan Stanley dropped their price objective on W.R. Berkley from $73.00 to $72.00 and set an "equal weight" rating on the stock in a report on Monday. Weiss Ratings restated a "buy (b)" rating on shares of W.R. Berkley in a report on Wednesday, January 21st. Finally, Jefferies Financial Group dropped their price objective on W.R. Berkley from $75.00 to $70.00 and set a "hold" rating on the stock in a report on Tuesday, January 27th. Four equities research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and four have assigned a Sell rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus target price of $69.06.

W.R. Berkley Stock Up 0.2%

NYSE:WRB traded up $0.13 during mid-day trading on Wednesday, reaching $66.81. The stock had a trading volume of 588,315 shares, compared to its average volume of 2,265,332. The business's 50 day moving average is $68.74 and its 200 day moving average is $71.33. W.R. Berkley has a fifty-two week low of $63.65 and a fifty-two week high of $78.96. The stock has a market cap of $25.02 billion, a P/E ratio of 15.01, a PEG ratio of 2.58 and a beta of 0.37. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.37 and a quick ratio of 0.37.

W.R. Berkley (NYSE:WRB - Get Free Report) last released its quarterly earnings data on Monday, January 26th. The insurance provider reported $1.13 EPS for the quarter, missing analysts' consensus estimates of $1.14 by ($0.01). W.R. Berkley had a return on equity of 18.17% and a net margin of 12.10%.The firm had revenue of $3.18 billion during the quarter, compared to analyst estimates of $3.18 billion. During the same quarter in the prior year, the company posted $1.13 EPS. The company's quarterly revenue was up 2.1% on a year-over-year basis. As a group, sell-side analysts predict that W.R. Berkley will post 4.33 earnings per share for the current year.

Insider Buying and Selling

In related news, major shareholder Sumitomo Insurance Co L. Mitsui purchased 370,000 shares of the stock in a transaction on Monday, January 26th. The shares were bought at an average price of $67.07 per share, for a total transaction of $24,815,900.00. Following the completion of the acquisition, the insider directly owned 54,959,504 shares in the company, valued at approximately $3,686,133,933.28. This trade represents a 0.68% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders purchased a total of 7,294,987 shares of company stock worth $503,481,336 in the last 90 days. Company insiders own 23.00% of the company's stock.

Hedge Funds Weigh In On W.R. Berkley

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Compass Financial Services Inc acquired a new position in W.R. Berkley during the third quarter valued at approximately $26,000. Entrust Financial LLC bought a new stake in shares of W.R. Berkley in the fourth quarter valued at approximately $25,000. Hazlett Burt & Watson Inc. boosted its position in shares of W.R. Berkley by 140.0% in the fourth quarter. Hazlett Burt & Watson Inc. now owns 360 shares of the insurance provider's stock valued at $26,000 after acquiring an additional 210 shares during the period. DV Equities LLC bought a new stake in shares of W.R. Berkley in the fourth quarter valued at approximately $29,000. Finally, Triumph Capital Management bought a new stake in shares of W.R. Berkley in the third quarter valued at approximately $35,000. Institutional investors and hedge funds own 68.82% of the company's stock.

Trending Headlines about W.R. Berkley

Here are the key news stories impacting W.R. Berkley this week:

• Positive Sentiment: Zacks Research raised multiple near‑ and medium‑term EPS estimates for WRB (small upward revisions to Q3 2026, Q3 2027, Q4 2027, FY2026 and FY2028). These steady, incremental upgrades suggest underwriters see slightly better earnings momentum, which supports valuation and helped lift the stock.
• Positive Sentiment: Insider and institutional accumulation: InsiderTrades reports heavy Q1 insider activity for WRB (37 acquisitions) and notes Sumitomo Insurance expanding its stake with an intent to reach ~15% ownership; institutions own ~70%. Large insider/institutional buying is a strong confidence signal and can reduce downside volatility. Top 5 Insider Buys From Q1: Buy, Sell, or Hold in Q2? (WRB)
• Neutral Sentiment: Income angle: A Seeking Alpha piece highlights WRB’s baby bonds as a discounted source of investment‑grade income — useful for yield‑focused investors but unlikely to move the equity much on its own. W. R. Berkley's Baby Bonds: Investment-Grade Income At A Discount
• Neutral Sentiment: Mixed sell‑side views: Coverage in The Globe and Mail notes conflicting analyst sentiment on WRB (some bullish estimate tweaks vs. at least one cautious firm), which can keep trading rangebound as investors weigh opposing views. Analysts Have Conflicting Sentiments on These Financial Companies: MS and WRB
• Negative Sentiment: Morgan Stanley published a pessimistic price forecast for WRB, which could cap upside if other investors follow the bear case or if the note leads to reduced buy‑side conviction. That caution may explain muted volume despite insider buying. Morgan Stanley Issues Pessimistic Forecast for W.R. Berkley

W.R. Berkley Company Profile

W. R. Berkley Corporation NYSE: WRB is a publicly traded insurance holding company that underwrites and sells commercial property and casualty insurance, specialty insurance products, and reinsurance. Headquartered in Greenwich, Connecticut, the company operates a portfolio of underwriting businesses that focus on niche and specialty commercial risks, offering coverage tailored to industries such as transportation, construction, professional services and other commercial lines.

The company's product mix includes primary and excess casualty, property, professional liability, environmental and other specialty lines, together with treaty and facultative reinsurance solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.